通过扰乱EBNA2/MYC轴,PARP1抑制可以阻止EBV+淋巴瘤的进展
Lisa Beatrice Caruso1, Giorgia Napoletani1, Samantha S Soldan1
1The Wistar Institute, Philadelphia, Pennsylvania, USA.
Journal of medical virology
|July 7, 2025
概括
通过重编程基因表达,PARP1抑制剂对EBV驱动的淋巴瘤表现出强大的抗瘤作用. 这种方法针对EBNA2/MYC途径,为EBV相关的癌症提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 病毒学 病毒学
背景情况:
- 聚 ((ADP-ribose) 聚合酶1 (PARP1) 调节爱斯坦-巴尔病毒 (EBV) 的潜伏时间.
- 在EBV阳性淋巴发育中PARP1抑制剂的治疗潜力仍然未被探索.
研究的目的:
- 研究PARP1抑制剂对EBV驱动的淋巴发育的治疗作用.
- 阐明EBV相关癌症中PARP1抑制的抗瘤活性背后的分子机制.
主要方法:
- 利用一种由EBV驱动的淋巴细胞 (LCLs) 的老鼠异种移植模型.
- 在体内和体外评估了PARP1抑制剂BMN 673对LCLs的影响.
- 分析了转录重编程,瘤基因表达 (MYC),病毒瘤蛋白 (EBNA2) 和关键蛋白质的染色体关联 (MYC,EBNA2,p53).
主要成果:
- 用BMN 673抑制PARP1对EBV驱动的LCLs表现出显著的抗瘤作用.
- 抑制PARP1导致了大量的转录重编程,主要是通过减少MYC瘤基因表达及其标.
- 减少病毒蛋白EBNA2的表达,并阻断了MYC,EBNA2和p53的染色体协会.
结论:
- 在EBV驱动的恶性转变中,PARP1起着至关重要的作用.
- 这种EBNA2/MYC通路是PARP1抑制剂的关键标.
- PARP1 抑制剂代表了对由EBNA2驱动的EBV相关癌症的有前途的治疗策略.
更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
Restarting Stalled Replication Forks
5.9K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Long-patch Base Excision Repair
7.2K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.2K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K


